Journal ArticleJCO Oncol Pract · October 2025
PURPOSE: Medical podcast integration into hematology/oncology fellowship curricula remains largely unstudied. We conducted a multicenter cluster randomized trial to evaluate the educational impact of a podcast-based curriculum (PC) when delivered alongside ...
Full textLink to itemCite
Journal ArticleOncologist · July 4, 2025
PURPOSE: This study aimed to evaluate the facilitators and barriers to self-advocacy and advocacy in the community of cervical and breast cancer survivors. METHODS: A mixed-methods approach was used to collect data from patients with breast and cervical ca ...
Full textLink to itemCite
Journal ArticleCurr Oncol Rep · May 2023
PURPOSE OF REVIEW: Cisplatin-based combination chemotherapy has been a standard of care in the perioperative management of muscle-invasive bladder cancer for years, but several novel therapies are under active investigation. This review aims to provide an ...
Full textLink to itemCite
Journal ArticleJ Geriatr Oncol · March 2023
INTRODUCTION: Older patients with cancer often require acute care treatment through emergency department (ED) visits and hospitalizations. This study investigates acute care utilization through ED visits and hospitalizations during treatment and in the two ...
Full textLink to itemCite
Journal ArticleJ Oncol Pharm Pract · June 2022
INTRODUCTION: Thrombotic thrombocytopenic purpura (TTP) is a life threatening type of thrombotic microangiopathy (TMA) caused by a deficiency in ADAMTS13. Here, we describe a case of TTP in association with pembrolizumab treatment for metastatic urothelial ...
Full textLink to itemCite
Journal ArticleCase Reports in Oncology · November 25, 2020
Immune thrombocytopenia (ITP) is a rare paraneoplastic syndrome of solid tumor malignancies. In previously described cases of renal cell carcinoma (RCC) associated with secondary ITP, treatment has consisted of nephrectomy, splenectomy, and corticosteroids ...
Full textCite
Journal ArticleClin Genitourin Cancer · February 2017
OBJECTIVE: To identify the predictors of time from initial diagnosis of metastatic castration-resistance prostate cancer (mCRPC) to all-cause death within the Shared Equal Access Regional Cancer Hospital cohort. PATIENTS AND METHODS: We performed a retrosp ...
Full textLink to itemCite
Journal ArticleUrology · October 2016
OBJECTIVE: To investigate predictors of time to metastasis among men treated with androgen deprivation therapy for nonmetastatic prostate cancer who developed castration-resistant prostate cancer (CRPC) within the Shared Equal Access Regional Cancer Hospit ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · December 2015
BACKGROUND: To evaluate PSA levels and kinetic cutoffs to predict positive bone scans for men with non-metastatic castration-resistant prostate cancer (CRPC) from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort. METHODS: Retrospective anal ...
Full textLink to itemCite
Journal ArticleJ Urol · April 2015
PURPOSE: We investigated imaging practice patterns in men with nonmetastatic (M0) castration resistant prostate cancer. MATERIALS AND METHODS: We analyzed data on 247 patients with documented M0 CRPC from the SEARCH database. Patients were selected regardl ...
Full textLink to itemCite
Journal ArticleJ Neurodev Disord · 2015
BACKGROUND: Previous research has found accumulating evidence for atypical reward processing in autism spectrum disorders (ASD), particularly in the context of social rewards. Yet, this line of research has focused largely on positive social reinforcement, ...
Full textOpen AccessLink to itemCite